Enveric Biosciences Announces Pricing of $10 Million Public Offering
February 11, 2022
Ryan Allway February 11th, 2022 Psychedelics, Top News NAPLES, Fla., Feb. 11, 2022 /PRNewswire/ – Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a neuroscience company developing next-generation, psychedelic-inspired mental health and oncology treatments, today announced the pricing of its previously announced underwritten public offering of 20,000,000 shares of its common... Read more
Blackhawk Growth’s MindBio Therapeutics Brings Digital Mental Health Technology To Psychedelics Clinical Trials
October 7, 2021
Ryan Allway October 7th, 2021 Psychedelics Vancouver, British Columbia – TheNewswire – October 7, 2021 – Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (Frankfurt:0JJ) (the “Company” or “Blackhawk”) is pleased to announce that MindBio Therapeutics is developing a mental health technology platform to integrate with psychedelic treatments in clinical trials in... Read more
Psychedelic Stock Review Initiates Coverage on Ehave Inc.
September 30, 2021
Ryan Allway September 30th, 2021 Psychedelics MIAMI, Sept. 30, 2021 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today the Psychedelic Stock Review has initiated coverage. “Ehave is about to release a number of digital... Read more
